MannKind Corp. (MNKD)

[jimmac]

Afrezza had a year with no issues. It's the real deal.

Most large companies don't add a new medicine until it's been out a year.
That way any risk or side effects can be caught early.

The second year is when the growth happens
If everything the first year goes well.

Sanofi mentioned upfront the Afezza growth will be slow initially.